Moderna Inc (MRNA)

[axelvento]

The vaccine and immunotherapy combination reportedly cleared the primary goal set by the researchers, with these patients experiencing significantly more time without their cancer returning on average than those who only received Keytruda (a metric known as recurrence-free survival).

Scientists have been greatly interested in personalized cancer vaccines for years, and this research has played a pivotal role in the development of mRNA vaccine technology, even before it was used as the base for covid-19 vaccines.

Many researchers have argued that combining these vaccines with immunotherapy drugs should further amplify their effect.